Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a phase 4, single center, randomized, open-labeled study. The primary objective of
the study is to compare effect of gemigliptin and acarbose on endothelial function.
Subjects are randomized to gemigliptin or acarbose group and maintained intial treatment for
4 weeks.